Vaccine preventable diseases (VPDs) have long been a significant threat to public health, causing widespread morbidity and mortality worldwide. Immunization, through the administration of vaccines, has been a transformative force in reducing the burden of VPDs. Vaccines have played a crucial role in preventing the spread of infectious diseases such as measles, mumps, rubella, polio, influenza, hepatitis B, and more. Routine vaccination programs, supported by international health organizations and governments, have led to the near-elimination of certain diseases in many regions. The effectiveness of vaccines is evident in the control and, in some cases, the eradication of once-prevalent diseases. For instance, the Global Polio Eradication Initiative has made substantial progress in reducing polio cases globally. Additionally, widespread vaccination campaigns have led to significant declines in measles-related deaths. Vaccination not only protects individuals but also contributes to community immunity, reducing the overall incidence of infectious diseases. Despite these successes, challenges persist in achieving equitable vaccine coverage globally. Barriers such as vaccine hesitancy, inadequate access to healthcare, and logistical challenges in delivering vaccines to remote areas contribute to gaps in immunization. Continued efforts are required to address these challenges, strengthen healthcare infrastructure, and ensure that vaccines reach every corner of the world, ultimately contributing to the goal of a healthier and more resilient global population.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain